Increasing Radiopharmaceutical Production with Cyclotrons Bolter the Market Growth

The global cyclotron market is anticipated to grow at a CAGR of 11.2% during the forecast period (2023-2030). Cyclotrons are crucial in producing isotopes used in therapeutic radiopharmaceuticals for treating conditions such as cancer and neurological disorders including Alzheimer’s. According to the International Atomic Energy Agency (IAEA), between 10 and 12% of radiopharmaceuticals are produced in cyclotrons globally, but the demand for cyclotrons is increasing as more of the radionuclides they produce are used in research, diagnosis, and treatment in a range of life-threatening diseases such as cancer, Parkinson’s, Alzheimer’s, and insomnia. There were over 1,200 cyclotrons in operation around the globe, producing important radionuclides and increasing the availability of nuclear medicine ultimately providing better and more effective diagnosis.  

Browse the full report description of “Cyclotron Market Size, Share & Trends Analysis Report by Product (Cyclotron 10-12MeV, Cyclotron 16-18MeV, Cyclotron 19-24MeV, and Cyclotron above 24MeV), by Application (Medical, and Industrial), Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/cyclotron-market

Further, technological advancements in positron emission tomography (PET) and single-photon emission computed tomography (SPECT) imaging have contributed to the demand for cyclotrons. These imaging techniques rely on radiopharmaceuticals produced with the help of cyclotrons. PET is used to produce high-quality 3D images of target organs or cells in the body to diagnose disease. According to the IAEA, hospitals in Portugal, a country of just 10 million, perform over 50,000 PET procedures per year. Globally, cyclotrons account for 95% of the production of radiopharmaceuticals used in PET. 

In addition, manufacturers emphasize partnerships and product launches to meet market demand for cyclotron. For instance, in January 2022, IBA, a pioneer in particle accelerator technology and the provider of radiopharmaceutical production solutions, launched a new low-energy, compact-size cyclotron, the Cyclone KEY. The new machine enabled small and medium-sized hospitals to produce their radiopharmaceutical products in-house while providing more widespread global access to diagnostic solutions in oncology, neurology, and cardiology.

Market Coverage

• The market number available for – 2023-2031

• Base year- 2023

• Forecast period- 2024-2031

• Segment Covered- 

o By Product

o By Application

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

Competitive Landscape- includes Advanced Cyclotron Systems, Inc., GE HealthCare Technologies Inc., Ion Beam Applications SA (IBA), Siemens Medical Solutions USA, Inc, and others. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Cyclotron Market Report Segment

By Product

• Cyclotron 10-12MeV
• Cyclotron 16-18MeV 
• Cyclotron 19-24MeV
• Cyclotron above 24MeV

By Application

• Medical
• Industrial

Global Cyclotron Market Report Segment by Region

North America

• United States

• Canada

Europe

• UK

• Germany

• Italy

• Spain

• France

• Rest of Europe 

Asia-Pacific

• China

• India

• Japan

• South Korea

• Rest of Asia-Pacific 

Rest of the World

• Latin America 

• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/cyclotron-market